MITQ vs REGN · rev $20.1M vs P/E 14, rev $14.34B
Moving iMage Technologies Inc (MITQ) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Moving iMage Technologies Inc (MITQ) is a communication equipment company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported MITQ revenue for 2024-06-30 was $20.1M. Net income was -$1.4M. Revenue was down 0.3% from 2023-06-30 to 2024-06-30. MITQ currently screens at market cap $7.2M.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
MITQ currently screens at market cap $7.2M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the MITQ and REGN stock pages for the full models.
Not investment advice.